SCHEMBL5736847

SCHEMBL5736847

CC(C)(C)OC(=O)N(CCCC(=O)O)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.51
HDAC1 Q13547 3/20 0.51
HDAC2 Q92769 3/20 0.51
NCOR2 Q9Y618 2/20 0.51
MAPK1 P28482 2/20 0.46
ADRA1A P35348 1/20 0.46
HDAC4 P56524 1/20 0.46
SLC6A3 Q01959 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
CTSL P07711 1/20 0.45
CTSB P07858 1/20 0.45
CTSS P25774 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6379732 0.96 HDAC1 (0.53) HDAC3HDAC1HDAC2NCOR2MAPK1
SCHEMBL6378615 0.95 HDAC1 (0.52) HDAC3HDAC1HDAC2NCOR2MAPK1
SCHEMBL4147838 0.92 HDAC1 (0.56) HDAC3HDAC1HDAC2NCOR2HDAC6
SCHEMBL8525848 0.89 HDAC3 (0.56) HDAC3HDAC1HDAC2NCOR2CTSL
SCHEMBL1848202 0.87 HDAC1 (0.52) HDAC3HDAC1HDAC2NCOR2HDAC6
SCHEMBL8021840 0.87 HDAC3 (0.55) HDAC3HDAC1HDAC2NCOR2CTSL
SCHEMBL3510728 0.87 TSHR (0.51) HDAC3HDAC1HDAC2NCOR2L3MBTL1
SCHEMBL13783897 0.86 CYP1A2 (0.54) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL5737640 0.86 HDAC1 (0.54) HDAC3HDAC1HDAC2NCOR2HDAC4
SCHEMBL19615968 0.86 HDAC3 (0.51) HDAC3HDAC1HDAC2NCOR2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154152-A1 INHIBITORS OF NAEGLERIA FOWLERI CLEMSON UNIVERSITY 2025-05-15 US disclosed
EP-1549309-A4 SOMATOSTATIN ANALOGUE COMPOUNDS CHEMBRIDGE RES LAB INC (US) 2006-05-17 EP disclosed
EP-1549309-A2 SOMATOSTATIN ANALOGUE COMPOUNDS ChemBridge Research Laboratories, Inc. (US) 2005-07-06 EP disclosed
US-6872827-B2 Somatostatin analogue compounds CHEMBRIDGE RESEARCH LABORATORIES, INC. (US) 2005-03-29 US disclosed
US-20040019069-A1 Somatostatin analogue compounds CHEMBRIDGE CORPORATION 2004-01-29 US disclosed
WO-2003090677-A2 SOMATOSTATIN ANALOGUE COMPOUNDS CHEMBRIDGE RESEARCH LAB., LLC (US) 2003-11-06 WO disclosed
US-6214833-B1 MADE BY ACYLATION ZAMBON GROUP S.P.A. (IT) 2001-04-10 US disclosed
EP-0970075-A1 PYRIMIDINONE-1,3-OXATHIOLANE DERIVATIVES WITH ANTIVIRAL ACTIVITY ZAMBON GROUP S.p.A. (IT) 2000-01-12 EP disclosed
WO-1998043972-A1 PYRIMIDINONE-1,3-OXATHIOLANE DERIVATIVES WITH ANTIVIRAL ACTIVITY ZAMBON GROUP S.P.A. (IT) 1998-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154152-A1 INHIBITORS OF NAEGLERIA FOWLERI SERPINB1, NAMPT, NIT2 HDAC3 2654/4885HDAC1 1499/4885HDAC2 1210/4885
US-20040019069-A1 Somatostatin analogue compounds SSTR2, SSTR1, SSTR4 HDAC3 345/4885HDAC1 1411/4885HDAC2 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.